Exelixis
EXEL
#1323
Rank
$17.16 B
Marketcap
$70.33
Share price
-0.52%
Change (1 day)
63.63%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company